MA27316A1 - Derives d'indoline-phenylsulfonamide - Google Patents
Derives d'indoline-phenylsulfonamideInfo
- Publication number
- MA27316A1 MA27316A1 MA28032A MA28032A MA27316A1 MA 27316 A1 MA27316 A1 MA 27316A1 MA 28032 A MA28032 A MA 28032A MA 28032 A MA28032 A MA 28032A MA 27316 A1 MA27316 A1 MA 27316A1
- Authority
- MA
- Morocco
- Prior art keywords
- derivatives
- indoline
- indolinephenylsulfonamide
- phenylsulfonamide derivatives
- phenylsulfonamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/96—Spiro-condensed ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
DERIVES D'INDOLINEPHENYLSULFONAMIDE La présente demande concerne de nouveaux dérivés d'indolinephénylsulfonamide substitués, des procédés pour leur préparation, et leur utilisation dans des médicaments, en particulier en tant que composés puissants d'activation de PPAR-delta pour la prophylaxie et/ou le traitement de troubles cardiovasculaires, en particulier de dyslipidémies et de maladies coronariennes.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10229777A DE10229777A1 (de) | 2002-07-03 | 2002-07-03 | Indolin-Phenylsulfonamid-Derivate |
Publications (1)
Publication Number | Publication Date |
---|---|
MA27316A1 true MA27316A1 (fr) | 2005-05-02 |
Family
ID=29796112
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA28032A MA27316A1 (fr) | 2002-07-03 | 2005-01-03 | Derives d'indoline-phenylsulfonamide |
Country Status (26)
Country | Link |
---|---|
US (1) | US20060100230A1 (fr) |
EP (1) | EP1519919A1 (fr) |
JP (1) | JP2005535649A (fr) |
CN (1) | CN1678581A (fr) |
AR (1) | AR040352A1 (fr) |
AU (1) | AU2003246638A1 (fr) |
BR (1) | BR0312549A (fr) |
CA (1) | CA2491477A1 (fr) |
DE (1) | DE10229777A1 (fr) |
EC (1) | ECSP055524A (fr) |
GT (1) | GT200300135A (fr) |
HN (1) | HN2003000196A (fr) |
HR (1) | HRP20050108A2 (fr) |
IL (1) | IL165924A0 (fr) |
MA (1) | MA27316A1 (fr) |
MX (1) | MXPA05000133A (fr) |
MY (1) | MY134641A (fr) |
NO (1) | NO20050579L (fr) |
NZ (1) | NZ537486A (fr) |
PE (1) | PE20040645A1 (fr) |
RU (1) | RU2328485C2 (fr) |
TW (1) | TW200418794A (fr) |
UA (1) | UA79003C2 (fr) |
UY (1) | UY27878A1 (fr) |
WO (1) | WO2004005253A1 (fr) |
ZA (1) | ZA200500013B (fr) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10335450A1 (de) * | 2003-08-02 | 2005-02-17 | Bayer Ag | Indolin-Sulfanilsäureamide |
DE10337839A1 (de) * | 2003-08-18 | 2005-03-17 | Bayer Healthcare Ag | Indolin-Derivate |
JP2007504271A (ja) * | 2003-09-05 | 2007-03-01 | ニューロジェン・コーポレーション | Crf1受容体リガンドである、ヘテロアリール縮合ピリジン類、ピラジン類及びピリミジン類 |
AR048523A1 (es) * | 2004-04-07 | 2006-05-03 | Kalypsys Inc | Compuestos con estructura de aril sulfonamida y sulfonilo como moduladores de ppar y metodos para tratar trastornos metabolicos |
DE602005024384D1 (de) | 2004-05-05 | 2010-12-09 | High Point Pharmaceuticals Llc | Neue verbindungen, ihre herstellung und verwendung |
EP1745014B1 (fr) | 2004-05-05 | 2011-07-06 | High Point Pharmaceuticals, LLC | Nouveaux composes, leur preparation et leur utilisation |
FR2869904B1 (fr) | 2004-05-07 | 2006-07-28 | Fournier S A Sa Lab | Modulateurs des recepteurs lxr |
FR2873694B1 (fr) * | 2004-07-27 | 2006-12-08 | Merck Sante Soc Par Actions Si | Nouveaux aza-indoles inhibiteurs de la mtp et apob |
MX2007005205A (es) * | 2004-10-29 | 2007-05-11 | Kalypsys Inc | Compuestos biciclicos sulfonilo-sustituidos como moduladores de receptores activados por el proliferador de la peroxisoma. |
CN101421258B (zh) * | 2004-10-29 | 2013-08-21 | 凯利普西斯公司 | 作为ppar调节剂的磺酰基取代的双环化合物 |
US20080131475A1 (en) * | 2005-01-18 | 2008-06-05 | David Saul Cohen | Methods of Use of Dual Ppar Agonist Compounds and Drug Delivery Devices Containing Such Compounds |
DE102005020229A1 (de) * | 2005-04-30 | 2006-11-09 | Bayer Healthcare Ag | Verwendung von Indolin-Phenylsulfonamid-Derivaten |
DE102005020230A1 (de) * | 2005-04-30 | 2006-11-09 | Bayer Healthcare Ag | Verwendung von Indolin-Phenylsulfonamid-Derivaten |
FR2886293B1 (fr) * | 2005-05-30 | 2007-08-24 | Fournier S A Sa Lab | Nouveaux composes de l'indoline |
EP1899302B1 (fr) | 2005-06-30 | 2011-10-19 | High Point Pharmaceuticals, LLC | Acides phénoxyacétiques en tant qu'activateurs de rapp-delta |
FR2890072A1 (fr) * | 2005-09-01 | 2007-03-02 | Fournier S A Sa Lab | Nouveaux composesde pyrrolopyridine |
WO2007071766A2 (fr) | 2005-12-22 | 2007-06-28 | Transtech Pharma | Nouveaux composes, leur preparation et leur utilisation |
EP1999098A2 (fr) | 2006-03-09 | 2008-12-10 | High Point Pharmaceuticals, LLC | Nouveaux composés, leur préparation et utilisation |
TWI315304B (en) * | 2006-08-31 | 2009-10-01 | Univ Taipei Medical | Indoline-sulfonamides compounds |
EP1932843A1 (fr) * | 2006-12-14 | 2008-06-18 | sanofi-aventis | Dérivés de sulfonyl-phenyl-2H(1,2,4) oxadiazole-5-one, procédés de préparation de ceux-ci et leur usage sous forme de médicaments |
WO2008091863A1 (fr) | 2007-01-23 | 2008-07-31 | Kalypsys, Inc. | Composés bicycliques substitués par sulfonyle utilisés comme modulateurs de ppar dans le traitement de la stéatohépatite non alcoolique |
TW200848021A (en) | 2007-03-06 | 2008-12-16 | Wyeth Corp | Sulfonylated heterocycles useful for modulation of the progesterone receptor |
PE20090159A1 (es) | 2007-03-08 | 2009-02-21 | Plexxikon Inc | COMPUESTOS DERIVADOS DE ACIDO INDOL-PROPIONICO COMO MODULADORES PPARs |
JP2011523664A (ja) | 2008-06-09 | 2011-08-18 | サノフィ−アベンティス | オキサジアゾロン頭部基を有する、環付加された(annelated)N−複素環式スルホンアミド、それらの製造方法および医薬としてのそれらの使用 |
WO2010000353A1 (fr) * | 2008-06-09 | 2010-01-07 | Sanofi-Aventis | Sulfonamides comprenant un hétérocycle et un groupe de tête oxadiazolone, procédés pour les préparer et leur utilisation comme produits pharmaceutiques |
WO2010047982A1 (fr) | 2008-10-22 | 2010-04-29 | Merck Sharp & Dohme Corp. | Nouveaux dérivés de benzimidazole cycliques utiles comme agents anti-diabétiques |
JP5557845B2 (ja) | 2008-10-31 | 2014-07-23 | メルク・シャープ・アンド・ドーム・コーポレーション | 糖尿病用剤として有用な新規環状ベンゾイミダゾール誘導体 |
EP2538784B1 (fr) | 2010-02-25 | 2015-09-09 | Merck Sharp & Dohme Corp. | Dérivés de benzimidazole utiles comme agents antidiabétiques |
KR101594002B1 (ko) | 2010-10-06 | 2016-02-15 | 글락소스미스클라인 엘엘씨 | Pi3 키나제 억제제로서의 벤즈이미다졸 유도체 |
WO2012064744A2 (fr) | 2010-11-08 | 2012-05-18 | Lycera Corporation | Tétrahydroquinoline et composés bicycliques associés pour l'inhibition de l'activité rorγ et le traitement de maladies |
EP2677869B1 (fr) | 2011-02-25 | 2017-11-08 | Merck Sharp & Dohme Corp. | Nouveaux dérivés d'azabenzimidazole cyclique utiles en tant qu'agents antidiabétiques |
WO2013169864A2 (fr) * | 2012-05-08 | 2013-11-14 | Lycera Corporation | Tétrahydro[1,8]naphtyridine-sulfonamide et composés apparentés pour utilisation en tant qu'agonistes de rorγ et dans le traitement d'une maladie |
MX367341B (es) | 2012-05-08 | 2019-08-14 | Merck Sharp & Dohme | Tetrahidronaftiridina y compuestos biciclicos relacionados para la inhibicion de la actividad de rorgamma y el tratamiento de enfermedades. |
RU2015106909A (ru) | 2012-08-02 | 2016-09-27 | Мерк Шарп И Доум Корп. | Антидиабетические трициклические соединения |
CA2898482A1 (fr) | 2013-02-22 | 2014-08-28 | Linda L. Brockunier | Composes bicycliques antidiabetiques |
WO2014139388A1 (fr) | 2013-03-14 | 2014-09-18 | Merck Sharp & Dohme Corp. | Nouveaux dérivés d'indole utiles en tant qu'agents antidiabétiques |
JP6192836B2 (ja) * | 2013-07-30 | 2017-09-06 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Rorcモジュレーターとしてのアザインドール化合物 |
EP3756661A1 (fr) | 2013-09-09 | 2020-12-30 | vTv Therapeutics LLC | Utilisation d'un agoniste de ppar-delta pour le traitement de l'atrophie musculaire |
WO2015051496A1 (fr) | 2013-10-08 | 2015-04-16 | Merck Sharp & Dohme Corp. | Composés tricycliques antidiabétiques |
CN103626767A (zh) * | 2013-12-04 | 2014-03-12 | 上海药明康德新药开发有限公司 | 区域选择性的氮杂吲哚及其合成方法 |
US9809561B2 (en) | 2013-12-20 | 2017-11-07 | Merck Sharp & Dohme Corp. | Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease |
US9783511B2 (en) | 2013-12-20 | 2017-10-10 | Lycera Corporation | Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of disease |
WO2015095788A1 (fr) | 2013-12-20 | 2015-06-25 | Merck Sharp & Dohme Corp. | Benzoxazine carbamates de 2-acylamidométhyle et de sulfonylamidométhyle pour l'inhibition de l'activité du rorgamma et le traitement d'une maladie |
AU2015222917A1 (en) | 2014-02-27 | 2016-09-15 | Lycera Corporation | Adoptive cellular therapy using an agonist of retinoic acid receptor-related orphan receptor gamma and related therapeutic methods |
EP3209641A4 (fr) | 2014-05-05 | 2018-06-06 | Lycera Corporation | Benzènesulfonamido et composés apparentés utilisés en tant qu'agonistes de ror et pour le traitement de maladie |
JP6728061B2 (ja) | 2014-05-05 | 2020-07-22 | リセラ・コーポレイションLycera Corporation | RORγアゴニストとして用いるテトラヒドロキノリンスルホンアミド及び関連化合物ならびに疾患の治療 |
AU2016219183B2 (en) | 2015-02-11 | 2020-06-11 | Merck Sharp & Dohme Corp. | Substituted pyrazole compounds as RORgammaT inhibitors and uses thereof |
EP3292119A4 (fr) | 2015-05-05 | 2018-10-03 | Lycera Corporation | SULFONAMIDES DE DIHYDRO-2H-BENZO[B][1,4]OXAZINE ET COMPOSÉS APPARENTÉS DESTINÉS À ÊTRE UTILISÉS COMME AGONISTES DE RORy ET POUR LE TRAITEMENT DE MALADIES |
AU2016276947A1 (en) | 2015-06-11 | 2017-12-14 | Lycera Corporation | Aryl dihydro-2h-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORy and the treatment of disease |
WO2017075185A1 (fr) | 2015-10-27 | 2017-05-04 | Merck Sharp & Dohme Corp. | Acides benzoïques à substitution hétéroaryle en tant qu'inhibiteurs de rorgammat et leurs utilisations |
US10344000B2 (en) | 2015-10-27 | 2019-07-09 | Merck Sharp & Dohme Corp. | Substituted bicyclic pyrazole compounds as RORgammaT inhibitors and uses thereof |
JP2018535958A (ja) | 2015-10-27 | 2018-12-06 | メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. | RORγT阻害薬としての置換インダゾール化合物及びその使用 |
EP3551176A4 (fr) | 2016-12-06 | 2020-06-24 | Merck Sharp & Dohme Corp. | Composés hétérocycliques antidiabétiques |
EP3558298A4 (fr) | 2016-12-20 | 2020-08-05 | Merck Sharp & Dohme Corp. | Composés de spirochromane antidiabétiques |
CN110483509B (zh) * | 2019-09-04 | 2020-08-25 | 温州大学 | 一种合成含氮杂环衍生物的方法 |
CN110627785B (zh) * | 2019-09-19 | 2021-06-25 | 温州大学 | 一种1,5-四氢萘啶衍生物的制备方法 |
EP4077332A4 (fr) * | 2019-12-18 | 2024-05-01 | The Regents of the University of California | Inhibiteurs de lin28 et leurs méthodes d'utilisation |
WO2023147309A1 (fr) | 2022-01-25 | 2023-08-03 | Reneo Pharmaceuticals, Inc. | Utilisation d'agonistes ppar-delta dans le traitement d'une maladie |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2708605A1 (fr) * | 1993-07-30 | 1995-02-10 | Sanofi Sa | Dérivés du N-sulfonylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant. |
KR100266467B1 (ko) * | 1995-09-27 | 2000-10-02 | 우에노 도시오 | 설폰아미드 유도체 |
FR2757157B1 (fr) * | 1996-12-13 | 1999-12-31 | Sanofi Sa | Derives d'indolin-2-one, procede pour leur preparation et compositions pharmaceutiques les contenant |
AU2001277723A1 (en) * | 2000-08-11 | 2002-02-25 | Nippon Chemiphar Co., Ltd. | Ppardelta activators |
-
2002
- 2002-07-03 DE DE10229777A patent/DE10229777A1/de not_active Withdrawn
-
2003
- 2003-06-30 BR BR0312549-1A patent/BR0312549A/pt not_active IP Right Cessation
- 2003-06-30 NZ NZ537486A patent/NZ537486A/en unknown
- 2003-06-30 MX MXPA05000133A patent/MXPA05000133A/es unknown
- 2003-06-30 WO PCT/EP2003/006896 patent/WO2004005253A1/fr not_active Application Discontinuation
- 2003-06-30 CA CA002491477A patent/CA2491477A1/fr not_active Abandoned
- 2003-06-30 RU RU2005102592/04A patent/RU2328485C2/ru not_active IP Right Cessation
- 2003-06-30 JP JP2004518622A patent/JP2005535649A/ja not_active Withdrawn
- 2003-06-30 US US10/519,125 patent/US20060100230A1/en not_active Abandoned
- 2003-06-30 EP EP03762547A patent/EP1519919A1/fr not_active Withdrawn
- 2003-06-30 CN CNA038209446A patent/CN1678581A/zh active Pending
- 2003-06-30 AR ARP030102373A patent/AR040352A1/es not_active Application Discontinuation
- 2003-06-30 AU AU2003246638A patent/AU2003246638A1/en not_active Abandoned
- 2003-06-30 UA UAA200500952A patent/UA79003C2/uk unknown
- 2003-07-01 MY MYPI20032474A patent/MY134641A/en unknown
- 2003-07-02 HN HN2003000196A patent/HN2003000196A/es unknown
- 2003-07-02 GT GT200300135A patent/GT200300135A/es unknown
- 2003-07-02 UY UY27878A patent/UY27878A1/es not_active Application Discontinuation
- 2003-07-02 TW TW092118027A patent/TW200418794A/zh unknown
- 2003-07-02 PE PE2003000668A patent/PE20040645A1/es not_active Application Discontinuation
-
2004
- 2004-12-22 IL IL16592404A patent/IL165924A0/xx unknown
-
2005
- 2005-01-03 ZA ZA200500013A patent/ZA200500013B/en unknown
- 2005-01-03 EC EC2005005524A patent/ECSP055524A/es unknown
- 2005-01-03 MA MA28032A patent/MA27316A1/fr unknown
- 2005-02-02 NO NO20050579A patent/NO20050579L/no not_active Application Discontinuation
- 2005-02-02 HR HR20050108A patent/HRP20050108A2/hr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
MY134641A (en) | 2007-12-31 |
US20060100230A1 (en) | 2006-05-11 |
WO2004005253A1 (fr) | 2004-01-15 |
GT200300135A (es) | 2004-03-17 |
CN1678581A (zh) | 2005-10-05 |
DE10229777A1 (de) | 2004-01-29 |
AU2003246638A1 (en) | 2004-01-23 |
HRP20050108A2 (hr) | 2006-04-30 |
UY27878A1 (es) | 2004-02-27 |
ECSP055524A (es) | 2005-03-10 |
PE20040645A1 (es) | 2004-10-29 |
MXPA05000133A (es) | 2005-04-11 |
BR0312549A (pt) | 2005-04-26 |
IL165924A0 (en) | 2006-01-15 |
JP2005535649A (ja) | 2005-11-24 |
RU2328485C2 (ru) | 2008-07-10 |
ZA200500013B (en) | 2006-03-29 |
AR040352A1 (es) | 2005-03-30 |
RU2005102592A (ru) | 2005-07-10 |
NO20050579L (no) | 2005-02-02 |
TW200418794A (en) | 2004-10-01 |
EP1519919A1 (fr) | 2005-04-06 |
UA79003C2 (en) | 2007-05-10 |
NZ537486A (en) | 2006-07-28 |
CA2491477A1 (fr) | 2004-01-15 |
HN2003000196A (es) | 2004-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA27316A1 (fr) | Derives d'indoline-phenylsulfonamide | |
MA27121A1 (fr) | Derives 2-(purin-9-yl)-tetrahydrofuran-3,4-diol | |
MA29692B1 (fr) | Derives de la xanthine en tant qu'agonistes selectifs du hm74a | |
MA26689A1 (fr) | Derives de tetrahydroquinoleine substitues nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN98017A1 (fr) | Derives de sulfonyluree, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
MA27608A1 (fr) | Derives d'hydroxyethylamine utilises pour le traitement de la maladie d'alzheimer | |
ATE423769T1 (de) | Fluor- und sulfonylaminohaltige, 3,6- disubstituierte azabicyclo 3.1.0 hexanderivate als muscarinrezeptorantagonisten | |
MA26727A1 (fr) | Derives nouveaux de pyrimidine inhibiteurs de sorbitol deshydrogenase, leur procede de preparation et compositions pharmaceutiques les contenant | |
MA26697A1 (fr) | Composes nouveaux inhibiteurs de gsk-3 et compositions pharmaceutiques les contenant | |
MA27428A1 (fr) | Derives de pyrimidine et leur utilisation en tant que modulateurs cb2 | |
MA27769A1 (fr) | Dérivées de 2-acylamino-4-phenylthiazole, leur préparation et leur application en thérapeutique | |
MA26729A1 (fr) | Modulateurs nouveaux des recepteurs de glucocorticoides, procede pour leur preparation et compositions pharmaceutiques les contenant | |
MA27156A1 (fr) | NUCLEOSIDES 3- β-D-RIBOFURANOSYLTHIAZOLO[4,5-d] PYRIDIMINE ET LES UTILISATIONS DE CELLES-CI | |
MA29170B1 (fr) | Derives puriniques agissant comme des agonistes du recepteur a2a | |
MA26733A1 (fr) | Derives d'isothiazole nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN97078A1 (fr) | Derives d'indole nouveaux, procede pour leur preparation et formulations pharmaceutiques les contenant | |
ATE440087T1 (de) | 2,4-diaminopyrimidinderivate, die sich als inhibitoren von pkc-theta eignen | |
MA25035A1 (fr) | Derives de 3-azabicyclo [3,1,0] hexane nouveaux, procede pour leur preparation et compositions les contenant | |
MA30089B1 (fr) | (arylsulfonyl)-pyrasolopiperidines | |
MA27692A1 (fr) | Composes derives de benzoxazinone, leur preparation et utilisation comme medicaments | |
SG151336A1 (en) | 1,3,4-oxadiazol-2-ones as ppar delta | |
TNSN97044A1 (fr) | Derives de quinoxalinedone, procedes et intermediaires pour leur preparation, et compositions pharmaceutiques les contenant. | |
MA27676A1 (fr) | 2-amino-6-(2-substitue-4-phenoxy)-substitue-pyridines, procede pour leur preparation et compositions pharmaceutiques les contenant | |
MA27844A1 (fr) | Derives pyrroliques substitues | |
MA28562B1 (fr) | 1,3,4-oxadiazol-2-ones comme modulateurs de ppar delta et leur utilisation |